MoonLake Immunotherapeutics (MLTX)
$43.81 5.6%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
6 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on MoonLake Immunotherapeutics, AI stock picks, stock alerts and much more.
MLTX AI Stock Analysis
AI stock analysis for MLTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like MoonLake Immunotherapeutics (MLTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
MLTX Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of MoonLake Immunotherapeutics (MLTX), currently trading at $43.81, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About MLTX
-
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies.
-
Symbol
MLTX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
2.8B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.78 0.5% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.08 8.9% |
4 |
 |
Moderna MRNA |
$34.06 0.9% |
4 |
 |
Anavex Life Sciences AVXL |
$9.21 9.3% |
6 |
 |
BridgeBio Pharma BBIO |
$33.79 0.9% |
7 |
MLTX Alternative Data
News Mentions
Sign up to access
Twitter Followers
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
MLTX Financials
MLTX Key Metrics
-
Total Revenue
$0
-
Net Income
-$35.9M
-
Earnings per Share
-$0.57
-
Free cash flow
-$25.4M
-
EBITDA
-$43.1M
-
EBITDA Ratio
0
-
Total Assets
$518.2M
MLTX 2-year Revenue & Income
MLTX 2-year Free Cash Flow
MLTX Technicals
MLTX SMA
MLTX RSI
FAQ
What's the current price of MoonLake Immunotherapeutics (MLTX) Stock?
The price of an MoonLake Immunotherapeutics (MLTX) share is $43.81.
What's the market cap of MoonLake Immunotherapeutics?
The current market cap of MoonLake Immunotherapeutics is 2.8B.
Should I buy or sell MLTX?
MoonLake Immunotherapeutics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, MoonLake Immunotherapeutics is better viewed as a hold or accumulate position while waiting for further developments.
Is MoonLake Immunotherapeutics a good investment?
The current analysis of MoonLake Immunotherapeutics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in MoonLake Immunotherapeutics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy MoonLake Immunotherapeutics (MLTX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for MoonLake Immunotherapeutics stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to MoonLake Immunotherapeutics (MLTX) that investors often compare it to?
MoonLake Immunotherapeutics (MLTX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for MoonLake Immunotherapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast MoonLake Immunotherapeutics' stock price to be around $42.95 in 2026. Starting from the current price of $43.81, this represents a 2% change in price, indicating a neutral outlook for the stock.
How to buy MoonLake Immunotherapeutics (MLTX) Stock?
MoonLake Immunotherapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy MoonLake Immunotherapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.